ABOUT 500 cases of human infection due to Cryptococcus neoformans have been described since Busse and Buschke separately presented descriptions of clinical findings in the same patient. In addition ...

This double-blind trial enrolled adults with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All patients received combination antifungal therapy of ...

A new short course of treatment for HIV-associated cryptococcal meningitis is as effective at preventing deaths as the current longer recommended regimen but causes far fewer serious side effects, ...

International HIV experts have reported approximately 250,000 fungal meningitis cases annually, in the AIDS report, sub-Saharan Africa contributing 73% of cases. This photomicrograph depicts ...

Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...

After entering the host, the leading cause of fungal meningitis, Cryptococcus neoformans, rapidly adapts by shrinking in size and acquiring other characteristics that allow it to better infect the ...

A photomicrograph of the Cryptococcus fungus. www.einstein.yu.edu South Africa has launched the world’s largest national screening programme to detect cryptococcal meningitis – an AIDS-defining fungal ...

The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year. It's difficult to treat because fungi are genetically quite similar to humans, so compounds that ...

The prevalence of cryptococcal infection was 2.9% (95% confidence interval [CI], 2.2% - 3.7%) from 1986 to 2012 among Americans with advanced HIV infection, according to a study published in the July ...

Though bacteria and viruses are often thought of as the causes of infections and illnesses, other microbes, such as fungi, can also cause disease. Fungal infections can spread through the blood to the ...

A new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and has the potential to reduce the length and cost of hospital admissions, a ...

To the Editor: Beardsley et al. (Feb. 11 issue) 1 report on a randomized clinical trial in which a group of patients with human immunodeficiency virus (HIV)–associated cryptococcal meningitis received ...